NASDAQ:ACIU
AC Immune SA Stock News
$3.54
-0.0300 (-0.84%)
At Close: May 24, 2024
Principia Sanofi Rumors, And Other News: The Good, Bad And Ugly Of Biopharma
12:51pm, Friday, 17'th Jul 2020
Principia up on Sanofi interest rumors. Qiagen N.V.
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 16) * AC Immune SA (NASDAQ: ACIU) ( announced clinical t
Here's Why AC Immune Jumped Higher Today
07:01pm, Thursday, 16'th Jul 2020
Investors are excited about the company advancing its Alzheimer's disease vaccine, but caution is warranted.
AC Immune Stock Catapults To Two-Year High On Alzheimer's News
05:21pm, Thursday, 16'th Jul 2020
AC Immune surged in massive volume Thursday after the small biotech company began dosing patients with an Alzheimer's treatment. The drug will be tested over 48 weeks in early-stage patients.
AC Immune Explodes 56% In Pre-Market On Alzheimer Study Initiation
12:29pm, Thursday, 16'th Jul 2020
Shares in AC Immune (ACIU) are surging 56% in Thursday’s pre-market trading after the biopharma announced the initiation of the second highest dosing group in the its Phase 1b/2a clinical trial ev
AC Immune Advances phospho-Tau Alzheimer’s Vaccine in Phase 1b/2a Study
11:00am, Thursday, 16'th Jul 2020
Interim data confirm the promising safety, tolerability and Tau-specific immunogenicity observed in the previous clinical study ACI-35.030 is a clinical stage vaccine generated.
Tau-PET Tracer PI-2620 Could Set New Standards for an Improved Diagnosis of Progressive Supranuclear Palsy
01:00pm, Tuesday, 07'th Jul 2020
BERLIN and LAUSANNE, Switzerland, July 07, 2020 -- Life Molecular Imaging and AC Immune SA (NASDAQ: ACIU) announce the publication of clinical data of the investigational.
How Much Of AC Immune SA (NASDAQ:ACIU) Do Insiders Own?
10:51am, Tuesday, 07'th Jul 2020
A look at the shareholders of AC Immune SA (NASDAQ:ACIU) can tell us which group is most powerful. Institutions often...
Hedge Funds Have Never Been This Bullish On AC Immune SA (ACIU)
06:59pm, Saturday, 04'th Jul 2020
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 821 13F filings that hedge funds and well-known value investors are required to file by the SEC. The 13F filin
AC Immune Announces Results of Annual General Meeting
11:21am, Friday, 26'th Jun 2020
AC Immune SA (ACIU), a Swiss-based, clinical-stage biopharmaceutical company with a broad pipeline focused on neurodegenerative diseases, announced AC Immune shareholders approved all of the resolutio
AC Immune CEO to Showcase Novel Target Programs at UBS Global Healthcare Conference
11:00am, Friday, 15'th May 2020
LAUSANNE, Switzerland, May 15, 2020 -- AC Immune SA (NASDAQ: ACIU), a Swiss-based, clinical-stage biopharmaceutical company with a broad pipeline focused on neurodegenerative.
AC Immune SA (NASDAQ:ACIU) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates
02:12pm, Wednesday, 06'th May 2020
As you might know, AC Immune SA (NASDAQ:ACIU) just kicked off its latest quarterly results with some very strong...
AC Immune (ACIU) Reports Q1 Loss, Tops Revenue Estimates
12:35pm, Monday, 04'th May 2020
AC Immune (ACIU) delivered earnings and revenue surprises of 47.06% and 24.54%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
AC Immune Reports Q1 2020 Financial Results and Provides Business Update
11:00am, Monday, 04'th May 2020
On track to meet the five clinical milestones expected in 2020 with no modifying guidance as a result of Covid-19Ongoing strong financial position with CHF 277.9 million in.
Axsome Shares Jump 25% on Alzheimer's Study Results
03:16pm, Tuesday, 28'th Apr 2020
Clinical trial of AX-05 showed drug reduces patient agitation Continue reading...
